BlackRock Science and Technology Trust II (BSTZ) is a closed-end management investment trust that seeks total return and income through a combination of current income, current gains, and long-term capital appreciation. The Trust invests at least 80% of its total assets in equity securities issued by U.S. and non-U.S. science and technology companies across all market capitalizations, selected for their growth potential from science and technology advancements; its portfolio includes equity securities, options, preferred securities, convertible securities, depositary receipts, non-U.S. securities, emerging market investments, restricted and illiquid investments, private company investments such as Databricks Inc. (16.24% weight) and PsiQuantum Corp. (6.40% weight), and corporate bonds. BSTZ commenced operations in June 2019 and is managed by BlackRock, with its principal place of business in Wilmington, Delaware.
In recent developments, the Trust's Board approved an update to its managed distribution plan effective with the October 2025 distribution cycle, transitioning from a floating rate to a level monthly distribution of $0.16250 per share alongside similar changes for affiliated funds BMEZ and BTX. Tender offers conducted in November 2024 were significantly oversubscribed, with BSTZ repurchasing approximately 1.85 million shares at $22.3440 per share on a pro rata basis from 19.7 million tendered shares, reflecting efforts to manage share supply and enhance shareholder value. These actions support the Trust's 12-year limited term structure, subject to possible extension or conversion to perpetual status, while maintaining focus on technology sector exposure including leading holdings like NVIDIA Corporation (8.75% weight).